Open Access Research

Conditional expression of human β-hexosaminidase in the neurons of Sandhoff disease rescues mice from neurodegeneration but not neuroinflammation

Stephanos Kyrkanides1,2*, Sabine M Brouxhon2, Ross H Tallents3, Jen-nie H Miller3, John A Olschowka4 and M K O’Banion4

Author Affiliations

1 Department of Children’s Dentistry, Stony Brook University, Stony Brook, NY, 11894-8701, USA

2 Health Science Center, Stony Brook University, Stony Brook, NY, 11794-8701, USA

3 Department of Dentistry, University of Rochester School of Medicine & Dentistry, Rochester, NY, 14642, USA

4 Neurobiology & Anatomy, University of Rochester School of Medicine & Dentistry, Rochester, NY, 14642, USA

For all author emails, please log on.

Journal of Neuroinflammation 2012, 9:186 doi:10.1186/1742-2094-9-186

Published: 4 August 2012

Abstract

This study evaluated whether GM2 ganglioside storage is necessary for neurodegeneration and neuroinflammation by performing β-hexosaminidase rescue experiments in neurons of HexB−/− mice. We developed a novel mouse model, whereby the expression of the human HEXB gene was targeted to neurons of HexB−/− mice by the Thy1 promoter. Despite β-hexosaminidase restoration in neurons was sufficient in rescuing HexB−/− mice from GM2 neuronal storage and neurodegeneration, brain inflammation persisted, including the presence of large numbers of reactive microglia/macrophages due to persisting GM2 presence in this cell type. In conclusion, our results suggest that neuroinflammation is not sufficient to elicit neurodegeneration as long as neuronal function is restored.

Keywords:
GM2 gangliosidosis; β-hexosaminidase; Mouse; Neuron; Sandhoff disease; Transgenic